The effect of A-factor on streptomycin resistance and productivity in Streptomyces griseus and S. bikiniensis was studied using A-factor-negative mutants.
Resistance of several of these mutants was markedly increased by adding A-factor to the growing medium, as also was their streptomycin productivity. The A-factor induced resistance was due to inactivation by streptomycin-6-phosphotransferase, and enzyme synthesis in these mutants was completely dependent on the presence of A-factor. In the case of S. griseus 2247 where streptomycin productivity was independent of A-factor, resistance and synthesis of the inactivating enzyme were also independent of A-factor.
A-Factor-negative mutants of S. griseus showed a decreased level of NADP-glycohydrolase and an increased level of several NADP-linked dehydrogenases, but these enzymes did not return to parental levels in cultures supplemented with A-factor. A-Factor seems to regulate streptomycin biosynthesis, not through an indirect metabolic sequence involving these enzymes but, more likely, by directly stimulating synthesis of enzyme(s) in the biosynthetic pathway.
A-Factor
(2S-isocapryloyl-3S-hydroxymethyl-r-butyrol actone) was first reported by KHOKHLOV et al.1~4) as a stimulatory factor for both streptomycin biosynthesis and spore formation in Streptomyces griseus and S. bikiniensis. We recently found that streptomycin-non-producing mutants derived from S. griseus FT-1 by UV-irradiation could be classified into major two classes, one blocked in the pathway of streptomycin biosynthesis and the other deficient in the synthesis of A-factor.5) The
A-factor-negative mutants were restored to streptomycin productivity when A-factor was added to the growth medium at very low concentration. We also observed that similar streptomycin-nonproducing mutants deficient for A-factor were obtained with high frequency by treatment with intercalating dyes or incubation at high temperature. It was suggested that a plasmid or transposable element controlled the biosynthesis of streptomycin through A-factor.
A close relationship between streptomycin resistance and productivity has been observed with antibiotic-producing strains. SHAW and PlWOWARSKI6,7) reported that treatment of S. bikiniensis with dyes resulted in loss of streptomycin resistance as well as loss of streptomycin productivity with high frequency. They observed that cell-free extracts of the dye-treated isolates did not inactivate streptomycin due to the absence of streptomycin-6-phosphotransferase activity. KIRBY and LEWIS8) also described asporogenic mutants of S. griseus and S. bikiniensis concomitantly lacking of streptomycin resistance and productivity and they suggested involvement of transposable genetic elements in this mutation.
The apparent resemblance between genetic control of streptomycin productivity and that of resistance led us to examine the effect of A-factor on the streptomycin resistance of S. griseus. Also The mechanism of the stimulatory effect of A-factor on streptomycin biosynthesis is also discussed.
Materials and Methods

Microorganisms
Streptomyces griseus FT-1 was obtained from Meiji Seika Kaisha, Ltd., Tokyo. S. griseus IFO 13189 and S. bikiniensis IFO 13350 were obtained from the Institute for Fermentation, Osaka. S. griseus 2247 was provided by R. NOMI, Hiroshima University. As reported previously,5) this strain does not require A-factor for streptomycin biosynthesis. The A-factor-negative mutant of S. griseus FT-1 was derived by UV-irradiation; those of S. griseus IFO 13189 and 2247 were obtained by acridine orange treatment and that of S. bikiniensis by incubation at high temperature.
Bacillus subtilis ATCC 6633 was used to bioassay streptomycin.
Medium
The liquid medium to produce streptomycin and test for streptomycin resistance was glucosemeat extract -peptone (GMP) medium containing 1 % glucose, 0.2 % yeast extract, 0.2 % meat extract, 0.4 % peptone, 0.5 % NaCl and 0.025 % MgSO4.7H2O, pH 7.0.10) Materials Synthetic A-factor [(3S)-(-)-A-factor] was provided by K. MORI11) of this department. Streptomycin, streptidine and O-a-L-dihydrostreptose(1-->4)streptidine were obtained from Meiji Seika Kaisha, Ltd. Escherichia coli alkaline phosphatase, adenosine 5'-triphosphate disodium salt (ATP), glucose-6-phosphate, isocitrate and 6-phosphogluconate were purchased from Sigma Chemical Company. Nicotinamideadenine dinucleotide phosphate (NADP) was purchased from Oriental Yeast Co., Ltd., Osaka.
Streptomycin Resistance
Cultures of each strain in 10 ml of GMP medium incubated in test tubes (21 mm diameter) for 2 days at 26.5°C were transferred at a dilution of 1: 200 into 10 ml of the fresh medium containing various concentrations of streptomycin with or without A-factor. Growth was observed after further incubation for 3 days at 26.5°C.
Assay of Streptomycin-inactivating Enzyme S. griseus and S. bikiniensis were grown in GMP medium. For the preparation of cell-free extracts and reaction mixture, the procedure described by PIWOWARSKI and SHAW7) was used. Cells were collected and washed with TMS buffer (10 mm tris-HCl, 10 mm magnesium chloride, 25 mm ammonium chloride, 0.6 mm 2-mercaptoethanol, pH 7.8). Washed cells were resuspended in TMS buffer and sonically disrupted. Sonicated cell suspensions were centrifuged at 25,000 xg for 20-30 minutes, and the supernatants were used as enzyme solutions. Protein was determined by the colorimetric assay of LOWRY et al.12) Assay mixtures containing equal volumes of cell-free extract, 1 mm streptomycin sulfate, 40 mm ATP (in water, pH 7.6) and 100 mm magnesium acetate were incubated for 1 hour at 30°C. As phosphorylated streptomycin is biologically inactive, the amount formed was measured by the decrease of antibiotic activity in the reaction mixture. Streptomycin was assayed by the paper disc method.
Streptomycin-phosphate was dephosphorylated by phosphatase. Assay mixtures containing equal volumes of the reaction mixture in which enzyme activity had been stopped by heat treatment, 50 mm tris-HCl, pH 9.0, and an adequate volume of E. coli alkaline phosphatase were incubated for 1 hour at 37°C.
Identification of Compounds
Streptomycin, streptidine, O-a-L-dihydrostreptose(1-->4)streptidine and their phosphorylated derivatives were identified by high performance liquid chromatography.
3)
Assay of NADP-glycohydrolase, Glucose-6-phosphate Dehydrogenase, Isocitrate Dehydrogenase and 6-Phosphogluconate Dehydrogenase
Cell-free extracts were prepared as described above, using 50 mm tris-HCl buffer, pH 7.2, substituting for TMS buffer.
NADP-glycohydrolase (EC 3.2.2.6) was measured according to VORONINA et al.1) Each assay mixture contained 0.3 ml of 2 mM NADP and approximately 100 ieg of extracted mycelial protein.
After incubation at 37°C, 2 ml of 1 M potassium cyanide was added to 0.1 ml of the reaction mixture and formation of the cyanide complex of intact NADP was measured at 325 nm.
NADP-linked dehydrogenases were assayed at 25°C by following the increase in absorbance of NADPH at 340 nm. The reaction mixtures described by GRAFE et a1.13> were used.
The assay mixture for glucose-6-phosphate dehydrogenase (EC 1.1.1.49) contained, in 3.0 ml: 2.6 ml of loo mm triethanolamine buffer, pH 7.6, 0.1 ml of 30 mm glucose-6-phosphate, 0.1 ml of 200 mm magnesium chloride, 0.1 ml of 12 mm NADP, and 0.1 ml of cell-free extracts.
The assay mixture for isocitrate dehydrogenase (EC 1.1.1.42) contained, in 3.0 ml: 2.6 ml of 100 mm triethanolamine buffer, pH 7.5, 0.1 ml of 150 mm isocitrate, 0.1 ml of 120 mm manganese sulfate, 0.1 ml of 30 mm NADP, and 0.1 ml of cell-free extracts.
The assay mixture for 6-phosphogluconate dehydrogenase (EC 1.1.1.44) contained, in 3.0 ml: 2.6 ml of 100 mm triethanolamine buffer, pH 7.4, 0.1 ml of 60 mm 6-phosphogluconate, 0.1 ml of 300 mm magnesium sulfate, 0.1 ml of 30 mm NADP, and 0.1 ml of cell-free extracts. One unit of these enzymes were expressed by amounts (nmoles) of the substrate decreased or the products increased per minute.
Results
Effect of A-Factor on Streptomycin Resistance In contrast, the A-factor-negative mutant of S. griseus 2247 was different. Although it had only half the resistance of its parent, it did not respond to the addition of A-factor. As reported in a previous paper," the streptomycin productivity of this strain was also independent of A-factor.
Effect of A-Factor on Streptomycin-phosphorylating Enzyme Activity
It is well known that at least part of the streptomycin resistance of the antibiotic-producing strains is due to inactivation of the antibiotic by a streptomycin-phosphorylating enzyme. Therefore, the effect of A-factor on the activity of the enzyme was examined with cell-free extracts of various strains grown in the presence and absence of A-factor. When streptomycin was incubated with cell-free extracts of all the parental strains in the presence of ATP and Mg2+, complete inactivation of the antibiotic was observed (Fig. 1) . Inactivating activity was absent from cell-free extracts of the A-factornegative mutants of S. griseus FT-1, IFO 13189 and S. bikiniensis IFO 13350, but it was unambiguously present when these mutants were grown in the presence of A-factor. Similar dependence of inactivating activity on A-factor was also observed with a double mutant of S. griseus FT-1 (class III mutant previously reported5)) which had a defect in streptomycin biosynthetic pathway in addition to A-factor deficiency (data not shown).
The mutant of S. griseus 2247 possessed inactivating activity, irrespective of A-factor supplementation.
Products of the streptomycin-inactivating enzyme reaction were analyzed by high performance liquid chromatography (Fig. 2) . When inactivation occurred during incubation with cell-free extracts of S. griseus FT-1 in the presence of ATP, the streptomycin peak disappeared and a new peak, probably streptomycin-phosphate, was clearly observed. No such change was observed in the absence of ATP or cell-free extracts. The product was converted to streptomycin by treatment with E. coli alkaline phosphatase. Moreover, streptidine and O-a-L-dihydrostreptose(l->4)streptidine were also phosphorylated by these cell-free extracts to the corresponding phosphorylated substances which were converted to the original substrates by treatment with alkaline phosphatase.
From these results, we conclude that the streptomycin-inactivating enzyme of S. griseus FT-1 is streptomycin-6-phos pho transferase. Cell-free extracts from S. griseus FT-1 was used. Experiments 1 -5 were carried out using streptomycin as substrate (1, before reaction; 2, after reaction; 3, reaction without ATP; 4, reaction without cell-free extracts; 5, treated with E. coli alkaline phosphatase after the inactivation reaction). Experiments 6 and 7 with streptidine as substrate (6, after reaction; 7, treated with phosphatase). Experiments 8 and 9 with O-a-L-dihydrostreptose(1->4)streptidine as substrate (8, after reaction; 9, treated with phosphatase).
10, control (a, streptomycin;
(1-->4)streptidine; c, streptidine). Cells collected from a seed culture grown in GMP medium at 28°C for 2 days, were washed once by centrifugation to remove A-factor and suspended in fresh GMP medium of the same volume. A 1-ml suspension was used to inoculate 100 ml of GMP medium (glucose, 3%) in a 500-m1 Sakaguchi flask. Cultivation was carried out at 28-C on a reciprocal shaker. 
NADP-linked Dehydrogenases
As shown in Table 2 , parental strains of S. griseus FT-1, IFO 13189 and 2247 have relatively high 
Discussion
The results in this paper show that streptomycin-6-phosphotransferase-mediated streptomycin resistance in S. griseus is induced by A-factor. Induction of the inactivating enzyme by A-factor occurred in the mutant having a defect in streptomycin biosynthetic pathway. This excludes a possibility that A-factor induces the enzyme synthesis indirectly followed by the activation of streptomycin production. The increase in streptomycin resistance brought about by A-factor in the negative mutants of S. griseus IFO 13189 and S. bikiniensis IFO 13350 was not as complete as observed in the mutant of S. griseus FT-1.
However, synthesis of the inactivating enzyme depended completely on A-factor, in all these strains.
It is well known that streptomycin resistance in antibiotic-producing strains is due to the presence of both the inactivating enzyme and a cell membrane barrier preventing penetration of the antibiotic.
It seems reasonable to assume that the elevated resistance of S. griseus FT-1 was largely due to an increase in the inactivating enzyme level. Because of this the response to A-factor is enhanced.
Considering also our earlier results,5) it is now evident that an unstable genetic determinant for A-factor biosynthesis controls streptomycin resistance as well as streptomycin productivity and spore formation in this organism. Control is exerted through the regulatory effect of A-factor. Mutants lacking streptomycin productivity as well as resistance were reported by SHAW and PlwowAR-SKI6,7) and KIRBY and LEWIS.8) It seems highly probable that their mutants were, in fact, A-factor deficient.
VORONINA et al.9) proposed a mechanism for A-factor stimulation of streptomycin productivity whereby A-factor primarily stimulated NADP-glycohydrolase.
This would increase the amount of phosphoadenosine diphosphoribose, which in turn would inhibit NADP-linked glucose-6-phosphate dehydrogenase and the pentose phosphate pathway. They assumed that glucose was preferentially used for streptomycin biosynthesis under such metabolic condition. We could confirm their observation that A-factor-negative mutants had lower NADP-glycohydrolase activity and higher NADPlinked dehydrogenases activities, probably due to the decreased level of phosphoadenosine diphosphoribose.
However, we could not observe recovery of parental enzyme levels in mutants to which Afactor was added. This suggests that A-factor is not a regulatory effector for these NADP-related enzymes, even though it evidently regulates the level of streptomycin-6-phosphotransferase.
In most of the A-factor-negative mutants tested, streptomycin production was restored by adding A-factor without significantly altering the level of the NADP-relating enzymes. Streptomycin productivity in the A-factor-negative mutant from strain 2247 was not affected by A-factor deficiency but it still had abnormal enzyme levels. These results indicate that there are no direct links between streptomycin biosynthesis and the activities of NADP-glycohydrolase and glucose-6-phosphate dehydrogenase.
A-Factor may affect streptomycin biosynthesis more directly by causing an increased level of enzyme(s) in the biosynthetic pathway as it does with streptomycin-6-phosphotransferase.
